A 1,2,4-triazolidinehydrazone compound containing a substituted phenyl ether structure, its preparation method and application

By synthesizing 1,2,4-triazolhydrazide hydrazones containing substituted phenyl ether structures, the problems of poor inhibitory effects and drug resistance risks of existing fungicides have been solved, achieving highly efficient inhibition of a variety of fungi and structural diversification.

CN123106560APending Publication Date: 2026-11-17NORTHEAST AGRICULTURAL UNIVERSITY
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202611358755.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-03
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing fungicides are not very effective in inhibiting fungal diseases such as gray mold, scab, and sheath blight. Long-term use of a single agent may lead to the risk of drug resistance. Existing compounds have limited molecular modification sites, simple synthetic routes, and insufficient broad-spectrum antifungal properties.

Method used

We designed and synthesized 1,2,4-triazole hydrazone compounds containing substituted phenyl ether structures. By combining 1,2,4-triazole, hydrazone, and Ar1-O-C6H4 fragments, we adjusted molecular electronic effects and conformations to form a variety of compounds. We also expanded the types of compound structures by using suitable aryloxy group construction conditions and condensation reaction routes.

Benefits of technology

The compound's structural types have been expanded, improving its inhibitory effects on fungi such as rice blast fungus, apple rot fungus, Fusarium graminearum, and Sclerotinia sclerotiorum. It also provides a synergistic structure with multiple active fragments, reducing the risk of drug resistance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123106560A_ABST
    Figure CN123106560A_ABST
Patent Text Reader

Abstract

This invention provides a 1,2,4-triazole hydrazone compound containing a substituted phenyl ether structure, its preparation method, and its application. The 1,2,4-triazole hydrazone compound containing a substituted phenyl ether structure of this invention is a compound represented by formula (I) or its isomers or mixtures thereof, or a pharmaceutically acceptable salt; the compound is prepared by aryloxylation, α-bromination, 1,2,4-triazole substitution, and condensation with a substituted phenylhydrazone. A1-A37 exhibit inhibitory activity against various plant pathogenic fungi, with A16 showing higher activity; this invention provides a new structural type for candidate compounds of plant fungicides.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of pesticide chemistry, and in particular to a 1,2,4-triazole hydrazone compound containing a substituted phenyl ether structure, its preparation method, and its application. Background Technology

[0002] Plant pathogenic fungi readily induce various crop diseases such as gray mold, rot, Fusarium head blight, sclerotinia rot, wilt, and sheath blight, severely reducing agricultural yields, damaging fruit quality, and significantly shortening the storage and preservation period of fruits and vegetables, causing continuous economic losses to agricultural production. Long-term repeated use of agents with similar sites of action may increase the risk of drug resistance; therefore, it is still necessary to develop candidate fungicides with novel structures and tunable substitution mechanisms.

[0003] Chinese patent application CN111978200A discloses biphenylamide derivatives with bactericidal activity. These compounds achieve antibacterial activity solely through a single biphenylamide skeleton, lacking a synergistic structure with multiple active fragments. They have limited molecular modification sites, a narrow range of tunable physicochemical properties, and synthetic routes that are only compatible with single aromatic substrates, resulting in poor broad-spectrum antifungal performance. Chinese patent application CN115784988A discloses multi-substituted nitrogen-containing heterocyclic derivatives, developed only for bacterial diseases such as bacterial wilt and soft rot, with weak inhibitory effects on mainstream fungal diseases such as gray mold, scab, and sheath blight.

[0004] In view of the shortcomings of the existing compounds, there is an urgent need to design and synthesize compounds with novel structures and superior bactericidal activity. Summary of the Invention

[0005] The purpose of this invention is to overcome the shortcomings of the prior art and provide a 1,2,4-triazole hydrazone compound containing a substituted phenyl ether structure, its preparation method, and its application.

[0006] To achieve the above objectives, the present invention is specifically implemented through the following technical solutions:

[0007] In a first aspect, the present invention provides a 1,2,4-triazolidinehydrazone compound containing a substituted phenyl ether structure, which is a compound represented by formula (I) or an isomer or mixture of isomers thereof, or a pharmaceutically acceptable salt thereof:

[0008]

[0009] Formula (I);

[0010] Wherein, the Ar 1 For R, which is chosen independently of one or two others 1 Substituted phenyl, or by an R 1 Substituted pyridin-2-yl;

[0011] The Ar2 It is a phenyl group or is formed by an R group. 2 Substituted phenyl;

[0012] The R 1 Each of the following is independently selected from fluorine, chlorine, bromine, methyl, and trifluoromethyl;

[0013] The R 2 It is selected from any one of fluorine, chlorine, bromine and trifluoromethyl.

[0014] Secondly, the present invention also provides a method for preparing the 1,2,4-triazole hydrazone compound containing a substituted phenyl ether structure, comprising the following steps:

[0015] Synthetic intermediates of aryloxyacetophenone ;

[0016] The aryloxyacetophenone intermediate was subjected to an α-bromination reaction with a brominating reagent to obtain an α-bromoketone intermediate. ;

[0017] The α-bromoketone intermediate was reacted with 1,2,4-triazole in the presence of a base to give a triazole-substituted ketone intermediate. ;

[0018] The triazole-substituted ketone intermediate was condensed with a substituted phenylhydrazine in the presence of a catalyst to obtain the compound shown in formula (I);

[0019] The chemical formula of the substituted phenylhydrazine is: .

[0020] Thirdly, the present invention also provides the application of the 1,2,4-triazole hydrazone compounds containing substituted phenyl ether structures in the preparation of plant pathogenic fungal inhibitors or plant fungicides.

[0021] Fourthly, the present invention also provides a method for preventing and controlling crop diseases, comprising the following steps:

[0022] Apply 1,2,4-triazolhydrazide compounds containing substituted phenyl ether structures as described above to crops.

[0023] The 1,2,4-triazole hydrazone compounds containing substituted phenyl ether structures and their preparation method of the present invention have the following advantages compared with the prior art:

[0024] 1. The 1,2,4-triazole hydrazone compounds of the present invention, containing substituted phenyl ether structures, combine 1,2,4-triazole, hydrazone, and Ar... 1 -O-C6H4 fragment combination, in which Ar 1The substituted phenyl or substituted pyridin-2-yl groups can be used; the 1,2,4-triazole structure, hydrazone structure, and phenoxy or pyridinoxy structure can affect the electronic effects, conformation, and hydrophobicity of the molecule. By combining the above structural fragments and adjusting the molecular structure through the left-side aryl type and the right-side phenylhydrazine ring substitution, candidate compounds with serial synthesis potential can be formed. This invention combines 1,2,4-triazole, hydrazone, and phenoxy or pyridinoxy fragments to obtain 44 specific compounds A1-A37 and B1-B7, expanding the left-side aryl structure types of this class of compounds. The tested A1-A37 compounds showed varying degrees of inhibitory effects against six plant pathogenic fungi, among which A16 showed a high inhibition rate against rice blast fungus, apple rot fungus, Fusarium graminearum, Sclerotinia sclerotiorum, and Rhizoctonia solani.

[0025] 2. The method for preparing 1,2,4-triazole hydrazone compounds containing substituted phenyl ether structures of the present invention uses either route S1-A or route S1-B for the aryloxyacetophenone intermediate I-1. After the formation of the corresponding aryloxyacetophenone intermediate I-1 via either route, α-bromination, 1,2,4-triazole substitution, and substituted phenylhydrazine condensation are carried out sequentially. The present invention uses suitable aryloxy construction conditions for benzene ring series and pyridine ring series respectively, while the subsequent three steps use the same reaction type, which facilitates serialized preparation. Attached Figure Description

[0026] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the accompanying drawings used in the description of the embodiments or the prior art will be briefly introduced below.

[0027] Figure 1 This is a schematic diagram of the preparation method of the compound represented by formula (I) of the present invention. Detailed Implementation

[0028] The present invention will now be clearly and completely described with reference to specific embodiments. Obviously, the described embodiments are only a part of the embodiments of the present invention, and not all of them. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.

[0029] To better understand the invention and not to limit its scope, all figures indicating amounts, percentages, and other numerical values ​​used in this application should, in all cases, be understood to be modified by the word "approximately." Therefore, unless specifically stated otherwise, the numerical parameters listed in the specification and appended claims are approximate values ​​and may vary depending on the desired properties being sought. Each numerical parameter should at least be considered as obtained based on reported significant figures and through conventional rounding methods.

[0030] It should be noted that the order of description of the following embodiments is not intended to limit the preferred order of embodiments. Furthermore, in the description of this application, the term "comprising" means "including but not limited to". Various embodiments of the present invention may exist in the form of a range; it should be understood that the description in the form of a range is merely for convenience and brevity and should not be construed as a rigid limitation on the scope of the invention; therefore, it should be considered that the range description has specifically disclosed all possible sub-ranges and single numerical values ​​within that range. For example, it should be considered that the range description from 1 to 6 has specifically disclosed sub-ranges, such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6, etc., and single digits within the range, such as 1, 2, 3, 4, 5, and 6, regardless of the range. Additionally, whenever a numerical range is referred to herein, it means including any referenced number (fraction or integer) within the referred range.

[0031] This application provides a 1,2,4-triazolidinehydrazone compound containing a substituted phenyl ether structure, which is a compound represented by formula (I) or an isomer or mixture of isomers thereof, or a pharmaceutically acceptable salt thereof:

[0032]

[0033] Formula (I);

[0034] Among them, Ar 1 For R, which is chosen independently of one or two others 1 Substituted phenyl, or by an R 1 Substituted pyridin-2-yl;

[0035] Ar 2 It is a phenyl group or is formed by an R group. 2 Substituted phenyl;

[0036] R 1 Each of the following is independently selected from fluorine, chlorine, bromine, methyl, and trifluoromethyl;

[0037] R 2 It is selected from any one of fluorine, chlorine, bromine and trifluoromethyl.

[0038] The compound represented by formula (I) may exist in E / Z geometric isomers, and the present invention includes its single isomer or mixture of isomers; Z (Zusammen, German "same side"): two high priority groups on the same side of the double bond; E (Entgegen, German "opposite side"): two high priority groups on opposite sides of the double bond (in opposite directions).

[0039] The compound represented by formula (I) of this application contains 1,2,4-triazole, hydrazone and Ar 1-O-C6H4 fragment combination, in which Ar 1 It can be a substituted phenyl or a substituted pyridin-2-yl; the 1,2,4-triazole structure, hydrazone structure, and phenoxy or pyridinoxy structure can affect the electronic effects, conformation, and hydrophobicity of the molecule; by combining the above structural fragments and adjusting the molecular structure through the aryl type on the left and the phenylhydrazine ring substitution on the right, candidate compounds with serial synthesis potential can be formed.

[0040] This invention combines 1,2,4-triazole, hydrazone, and phenoxy or pyridinoxy fragments to obtain 44 specific compounds, A1-A37 and B1-B7, expanding the left-side aryl structure types of this class of compounds. The tested compounds A1-A37 showed varying degrees of inhibitory activity against six plant pathogenic fungi, with A16 exhibiting a high inhibition rate against *Fusarium graminearum*, *Fusarium graminearum*, *Sclerotinia sclerotiorum*, and *Rhizoctonia solani*.

[0041] In some embodiments, when Ar 1 By an R 1 When replacing, R 1 The substitution position is selected from 2, 3, or 4 bits; when Ar 1 By two R 1 When replacing, the two Rs 1 The replacement positions are 2 and 4.

[0042] In some embodiments, Ar 1 It is selected from any one of 3-(trifluoromethyl)pyridin-2-yl, 3-chloropyridin-2-yl, 5-(trifluoromethyl)pyridin-2-yl, 6-(trifluoromethyl)pyridin-2-yl, 6-chloropyridin-2-yl and 6-bromopyridin-2-yl, 4-fluorophenyl, 4-chlorophenyl, 4-bromophenyl, 3-fluorophenyl, 3-chlorophenyl, 3-bromophenyl, 3-(trifluoromethyl)phenyl, 2-fluorophenyl, 2-chlorophenyl, 2-bromophenyl, 2-fluoro-4-bromophenyl, 2-bromo-4-chlorophenyl, 2,4-dichlorophenyl, 4-methylphenyl, 2-fluoro-4-chlorophenyl, 2,4-difluorophenyl, 2-methylphenyl, and 2,4-dibromophenyl;

[0043] Ar 2 It is selected from any one of phenyl, 4-fluorophenyl, 4-chlorophenyl, 4-bromophenyl, 3-(trifluoromethyl)phenyl and 4-(trifluoromethyl)phenyl.

[0044] In some embodiments, the compound is selected from any of the following Ar 1 and Ar 2 The compounds A1~A37 and B1~B7 determined by the combination: Specifically, in this invention, the A series is Ar 1 For compounds that substitute phenyl groups, the B series consists of Ar... 1Compounds substituted with pyridine-2-yl; Ar of A1-A37 and B1-B7 1 Ar 2 The composition and basic physicochemical data are shown in Tables 1-3.

[0045] Table 1 - Basic physicochemical data of compounds A1~A25

[0046]

[0047] Table 2 - Basic physicochemical data of compounds A26~A37

[0048]

[0049] Table 3 - Basic physicochemical data of compounds B1~B7

[0050]

[0051] Note: The yield of S4 in Tables 1-3 is the single-step yield of the condensation step S4 of the target compound based on the actual amount of intermediate I-3 fed. The calculation formula is: S4 yield (%) = amount of target compound ÷ amount of actual I-3 fed × 100%.

[0052] Specifically, the structural formulas of compounds A1-A37 are shown below:

[0053] , , , , , , , , , , , , , , , , , , , , , , , ,

[0054] , , , , , ... , , , , , , .

[0055] Specifically, the structural formulas of compounds B1-B7 are shown below:

[0056] , , , , , , .

[0057] Based on the same inventive concept, the present invention also provides a method for preparing the compound represented by formula (I) above, characterized by comprising the following steps:

[0058] S1, intermediate for the synthesis of aryloxyacetophenone ;

[0059] S2. The aryloxyacetophenone intermediate is subjected to an α-bromination reaction with a brominating reagent to obtain an α-bromoketone intermediate. ;

[0060] S3. The α-bromoketone intermediate is reacted with 1,2,4-triazole in the presence of a base to give the triazole-substituted ketone intermediate. ;

[0061] S4. The triazole-substituted ketone intermediate was condensed with the substituted phenylhydrazine in the presence of a catalyst to obtain the compound shown in formula (I).

[0062] The chemical formula of the substituted phenylhydrazine is: .

[0063] In some embodiments, the aryloxyacetophenone intermediate is a phenoxyacetophenone intermediate. or pyridoxyacetophenone intermediate n = 1 or 2;

[0064] If the chemical formula of the aryloxyacetophenone intermediate is phenoxyacetophenone intermediate, its preparation method includes the following steps:

[0065] The substituted phenol was reacted with 4-fluoroacetophenone in the presence of a base to give the phenoxyacetophenone intermediate; the chemical formula of the substituted phenol is [insert chemical formula here]. ;

[0066] If the chemical formula of the aryloxyacetophenone intermediate is pyridinoxyacetophenone intermediate, its preparation method includes the following steps: reacting a substituted 2-halopyridine with 4-hydroxyacetophenone in the presence of a base to obtain the pyridinoxyacetophenone intermediate; the chemical formula of the substituted 2-halopyridine is... X is Cl or Br.

[0067] In some embodiments, in the step of reacting substituted phenol with 4-fluoroacetophenone in the presence of a base to obtain a phenoxyacetophenone intermediate, the base is potassium carbonate, the solvent used is N,N-dimethylformamide, the reaction temperature is 130~135℃, and the reaction time is 12~15 h; the molar ratio of substituted phenol, 4-fluoroacetophenone and potassium carbonate is (1~1.5):(1.1~1.5):2;

[0068] In the step of reacting substituted 2-halopyridine with 4-hydroxyacetophenone in the presence of a base to obtain the pyridoxyacetophenone intermediate, the substituted 2-halopyridine is selected from one of 2-chloro-3-(trifluoromethyl)pyridine, 2,3-dichloropyridine, 2-chloro-6-(trifluoromethyl)pyridine, 2,6-dichloropyridine, 2-chloro-5-(trifluoromethyl)pyridine, and 2,6-dibromopyridine; the base is cesium carbonate, the solvent is dimethyl sulfoxide, the reaction temperature is 110~120℃, and the reaction time is 12~15h; the molar ratio of substituted 2-halopyridine, 4-hydroxyacetophenone, and cesium carbonate is (1~1.5):(1~1.5):2.

[0069] In the step of reacting the aryloxyacetophenone intermediate with a brominating reagent via an α-bromination reaction to obtain an α-bromoketone intermediate, the brominating reagent is N-bromosuccinimide, the catalyst is p-toluenesulfonic acid monohydrate, the solvent is acetonitrile, the reaction temperature is 80-85 °C, and the reaction time is 8-10 h; the molar ratio of the aryloxyacetophenone intermediate, N-bromosuccinimide, and p-toluenesulfonic acid monohydrate is (1-1.5):(1.5-2.0):0.1.

[0070] In the step of reacting the α-bromoketone intermediate with 1,2,4-triazole in the presence of a base to obtain the triazole-substituted ketone intermediate, the base is potassium carbonate, the solvent is acetone, the reaction temperature is 0~2 ℃, and the reaction time is 2~4 h; the molar ratio of α-bromoketone, 1,2,4-triazole, and potassium carbonate is (1~1.5):(1.5~2.0):2.

[0071] In the step of condensing a triazole-substituted ketone intermediate with a substituted phenylhydrazine in the presence of a catalyst to obtain the compound shown in formula (I), the catalyst is acetic acid, the solvent is ethanol, the reaction temperature is 80~85 °C, and the reaction time is 8~10 h; the molar ratio of the triazole-substituted ketone intermediate to the substituted phenylhydrazine is (1~1.5):2.

[0072] Further reference Figure 1 As shown, it is a schematic diagram of the preparation method of the compound represented by formula (I) of the present invention; wherein, according to Ar 1For the type of intermediate, in step S1, the aryloxyacetophenone intermediate I-1 is prepared using either route S1-A or route S1-B. After forming the corresponding aryloxyacetophenone intermediate I-1 via either route, α-bromination, 1,2,4-triazole substitution, and substituted phenylhydrazine condensation are performed sequentially. The general synthetic route is shown in [reference needed]. Figure 1 This invention employs suitable aryloxy group construction conditions for both benzene ring and pyridine ring series, while the subsequent three reaction steps use the same reaction type, facilitating serialized preparation.

[0073] In route S1-A, an optional substituted phenol is reacted with 4-fluoroacetophenone in N,N-dimethylformamide (DMF) in the presence of potassium carbonate to give phenoxyacetophenone intermediate I-1A;

[0074] In route S1-B, an optional substituted 2-halopyridine is reacted with 4-hydroxyacetophenone in dimethyl sulfoxide (DMSO) in the presence of cesium carbonate to give pyridoxyacetophenone intermediate I-1B. Phenoxyacetophenone intermediate I-1A and pyridoxyacetophenone intermediate I-1B are collectively referred to as aryloxyacetophenone intermediate I-1.

[0075] In step S2, aryloxyacetophenone intermediate I-1 is reacted with N-bromosuccinimide (NBS) in acetonitrile (MeCN) under the catalysis of p-toluenesulfonic acid monohydrate (p-TsOH·H2O) to obtain α-bromoketone intermediate I-2;

[0076] In step S3, α-bromoketone intermediate I-2 is reacted with 1,2,4-triazole in acetone in the presence of potassium carbonate to obtain triazole substituted ketone intermediate I-3.

[0077] In step S4, the triazole-substituted ketone intermediate I-3 is condensed with an optional substituted phenylhydrazine in ethanol (EtOH) under the catalysis of acetic acid (AcOH) to obtain the compound shown in formula (I).

[0078] Based on the same inventive concept, the present invention also provides the application of the above-mentioned 1,2,4-triazole hydrazone compounds containing substituted phenyl ether structures in the preparation of plant pathogenic fungicide inhibitors or plant fungicides.

[0079] In some embodiments, the plant pathogenic fungus is selected from at least one of rice blast fungus, apple rot fungus, Fusarium graminearum, Sclerotinia sclerotiorum, Fusarium oxysporum, and Rhizoctonia solani.

[0080] Based on the same inventive concept, the present invention also provides a method for preventing and controlling crop diseases, comprising the following steps:

[0081] The above-mentioned 1,2,4-triazole hydrazone compounds containing substituted phenyl ether structures were applied to crops.

[0082] The following specific embodiments further illustrate the 1,2,4-triazolidinehydrazone compounds containing substituted phenyl ether structures of the present invention, their preparation methods, and applications. This section further illustrates the content of the present invention in conjunction with specific embodiments, but should not be construed as limiting the present invention. Unless otherwise specified, the technical means used in the embodiments are conventional means well known to those skilled in the art. Reagents and solvents not specifically mentioned can be obtained commercially, and the reaction process can be monitored by thin-layer chromatography. The compound numbers correspond to the substitution combinations listed in Table 1. This application does not repeat all the preparation examples of A1-A37 and B1-B7 one by one. For compounds not listed separately, they can be prepared by following the corresponding general steps, using the substituted phenols or substituted 2-halopyridines and substituted phenylhydrazines corresponding to Table 1. The examples of target compounds mainly list the feed, reaction conditions, yield, appearance, and melting point.

[0083] Example 1

[0084] Preparation of benzene ring intermediate I-1

[0085] Represented by the 4-bromophenol series, 6.00 g (34.68 mmol) of 4-bromophenol, 5.27 g (38.15 mmol) of 4-fluoroacetophenone, and 9.59 g (69.36 mmol) of anhydrous potassium carbonate were added to 40 mL of N,N-dimethylformamide, and the mixture was stirred at 130 °C for 12 h. After the reaction was completed, the mixture was cooled to room temperature, poured into water, extracted with ethyl acetate, and the organic phases were combined. The mixture was washed with water, washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The solution was purified by silica gel column chromatography using dichloromethane and petroleum ether in a 1:1 volume ratio as eluent to obtain intermediate I-1 in 75.3% yield.

[0086] Example 2

[0087] General preparation of α-bromointermediate I-2

[0088] 9.00 g (30.91 mmol) of intermediate I-1 prepared in Example 1, 8.25 g (46.37 mmol) of N-bromosuccinimide, and 0.59 g (3.09 mmol) of p-toluenesulfonic acid monohydrate were added to 150 mL of acetonitrile and reacted at 80 °C for 8–10 h. After the reaction was complete, the mixture was cooled and the acetonitrile was removed under reduced pressure. The residue was extracted with water and then extracted with dichloromethane. The organic phases were combined and concentrated under reduced pressure. The mixture was purified by silica gel column chromatography using dichloromethane and petroleum ether at a volume ratio of 1:1 to obtain intermediate I-2, with a representative yield of 62.9%.

[0089] Example 3 General preparation of 1,2,4-triazole substituted intermediate I-3

[0090] At 0°C, 7.50 g (20.27 mmol) of intermediate I-2 prepared in Example 2, 2.10 g (30.40 mmol) of 1,2,4-triazole, and 5.60 g (40.54 mmol) of anhydrous potassium carbonate were added to 150 mL of acetone, and the mixture was stirred for 2 h. After the reaction was complete, the acetone was removed under reduced pressure, and the residue was extracted with ethyl acetate. The organic phases were combined, washed with saturated sodium chloride solution, dried over anhydrous sodium sulfate, filtered, concentrated under reduced pressure, and purified by silica gel column chromatography using dichloromethane and methanol at a volume ratio of 200:1 to obtain intermediate I-3, with a representative yield of 82.65%.

[0091] Example 4

[0092] General preparation of target compounds

[0093] Intermediate I-3 prepared in Example 3 was added to anhydrous ethanol at a molar ratio of 1:2 with the corresponding substituted phenylhydrazine, and a catalytic amount of acetic acid was added. The reaction was carried out at 80°C for 8 h. After the reaction was completed, the mixture was cooled and concentrated under reduced pressure. The crude product was purified by silica gel column chromatography using dichloromethane and methanol at a volume ratio of 300:1 as eluent to obtain the target compound.

[0094] Example 5

[0095] Preparation of compound A1

[0096] Compound A1 was prepared using the general method described in Example 4, with 4-fluorosubstituted intermediate I-3 and phenylhydrazine as raw materials, in a yield of 44.0%. It was a brown solid with a melting point of 153.3-153.4 °C.

[0097] Example 6

[0098] Preparation of compound A3

[0099] 6.00 g (16.75 mmol) of 4-bromosubstituted intermediate I-3 and 3.62 g (33.50 mmol) of phenylhydrazine were added to 150 mL of anhydrous ethanol, followed by 2 drops of acetic acid. The mixture was reacted at 80 °C for 8 h. After post-treatment and purification according to the method described in Example 4, compound A3 was obtained in 40.9% yield as a white solid with a melting point of 196.0–196.6 °C.

[0100] Example 7

[0101] Preparation of compound A4

[0102] Compound A4 was prepared using the general method described in Example 4, with 3-fluorosubstituted intermediate I-3 and phenylhydrazine as raw materials, in a yield of 43.5%. It was a yellow solid with a melting point of 119.2-119.7 °C.

[0103] Example 8

[0104] Preparation of compound A7

[0105] Compound A7 was prepared using the general method described in Example 4, with 3-(trifluoromethyl)-substituted intermediate I-3 and phenylhydrazine as raw materials, in a yield of 37.9%. It was a yellow solid with a melting point of 138.8-139.3 °C.

[0106] Example 9

[0107] Preparation of compound A10

[0108] Compound A10 was prepared using the general method described in Example 4, with 2-bromosubstituted intermediate I-3 and phenylhydrazine as raw materials, in a yield of 30.8%. It was a white solid with a melting point of 168.3-168.4 °C.

[0109] Example 10

[0110] Preparation of compound A11

[0111] Compound A11 was prepared using the general method described in Example 4, with 2-fluoro-4-bromosubstituted intermediate I-3 and phenylhydrazine as raw materials, in a yield of 30.3%. It was a white solid with a melting point of 182.1-183.1 °C.

[0112] Example 11

[0113] Preparation of compound A16

[0114] Compound A16 was prepared using the general method described in Example 4, with 4-methyl-substituted intermediate I-3 and 4-fluorophenylhydrazine as raw materials, in a yield of 37.7%. It was a white solid with a melting point of 149.2-149.8 °C.

[0115] Example 12

[0116] Preparation of compound A20

[0117] Compound A20 was prepared using the general method described in Example 4, with 3-(trifluoromethyl)-substituted intermediates I-3 and 4-fluorophenylhydrazine as raw materials, in a yield of 35.9%. It was a white solid with a melting point of 117.4-117.9 °C.

[0118] Example 13

[0119] Preparation of compound A25

[0120] Compound A25 was prepared using the general method described in Example 4, with 2-bromo-4-chloro-substituted intermediate I-3 and 4-fluorophenylhydrazine as raw materials, in a yield of 24.6%. It was a pale yellow solid with a melting point of 148.7-149.0 °C.

[0121] Example 14

[0122] Preparation of compound A28

[0123] Compound A28 was prepared using the general method described in Example 4, with 4-bromosubstituted intermediate I-3 and 4-chlorophenylhydrazine as raw materials, in a yield of 37.3%. It was a white solid with a melting point of 166.3-166.6 °C.

[0124] Example 15

[0125] Preparation of compound A30

[0126] Compound A30 was prepared using the general method described in Example 4, with 2-chloro-substituted intermediate I-3 and 4-(trifluoromethyl)phenylhydrazine as raw materials, in a yield of 34.0%. It was a white solid with a melting point of 221.4-221.7 °C.

[0127] Example 16

[0128] Preparation of compound A35

[0129] Compound A35 was prepared using the general method described in Example 4, with 2,4-difluorosubstituted intermediate I-3 and 4-(trifluoromethyl)phenylhydrazine as raw materials, in a yield of 28.1%. It was a white solid with a melting point of 187.6-187.7 °C.

[0130] Example 17

[0131] Preparation of pyridine ring series intermediate I-1

[0132] Using the substrate used in B1 as an example, 5.00 g (27.54 mmol) of 2-chloro-3-(trifluoromethyl)pyridine, 3.75 g (27.54 mmol) of 4-hydroxyacetophenone, and 17.95 g (55.08 mmol) of cesium carbonate were added to 70 mL of dimethyl sulfoxide, and the mixture was heated and stirred at 110 °C for 12 h. After the reaction was completed, the mixture was cooled to room temperature, water was added to the reaction solution and stirred, and after the solid precipitated, it was filtered. The filter cake was washed with water and dried under vacuum to obtain 6.00 g (21.33 mmol) of pyridinoxyacetophenone intermediate I-1 corresponding to B1, with a yield of 77.5%.

[0133] The remaining B-series intermediate I-1 was prepared using the same method as in Example 17. B2 was prepared using 5.00 g (27.54 mmol) of 2-chloro-3-(trifluoromethyl)pyridine to give I-1 6.50 g (23.11 mmol), with a yield of 83.9%; B3 was prepared using 5.00 g (33.79 mmol) of 2,3-dichloropyridine to give I-1 5.00 g (20.19 mmol), with a yield of 59.7%; B4 was prepared using 5.00 g (27.54 mmol) of 2-chloro-6-(trifluoromethyl)pyridine to give I-1 4.60 g (16.36 mmol), with a yield of 59.4%; B5 was prepared using 5.00 g (33.79 mmol) of 2,6-dichloropyridine to give I-1 5.30 g (21.40 mmol), with a yield of 63.3%; B6 was prepared using 5.00 g (27.54 mmol) of 2-chloro-5-(trifluoromethyl)pyridine to give I-1 6.50 g (23.11 mmol), with a yield of 83.9%; B6 was prepared using 5.00 g (27.54 mmol) of 2-chloro-5-(trifluoromethyl)pyridine to give I-1 5.30 g (21.40 mmol), with a yield of 63.3%; Using 2,6-dibromopyridine (5.00 g, 21.11 mmol), I-1 was obtained as 6.00 g (21.33 mmol), yielding 77.5%; B7 was obtained as 4.80 g (16.43 mmol) of I-1 (5.00 g, 21.11 mmol), yielding 77.8%. Each batch of I-1 was prepared into I-2 and I-3 sequentially according to the methods described in Examples 2 and 3. The actual separation data were as follows: B1 yielded 4.00 g (11.11 mmol) of I-2 (52.1%) and 2.30 g (6.60 mmol) of I-3 (59.5%); B2 yielded 3.50 g (9.72 mmol) of I-2 (42.0%) and 2.00 g (5.74 mmol) of I-3 (59.1%); B3 yielded 3.00 g (9.19 mmol) of I-2 (45.5%) and 1.80 g (5.72 mmol) of I-3 (62.3%); B4 yielded 2.70 g (7.50 mmol) of I-2 (45.8%) and 1.50 g (4.31 mmol) of I-3 (4.30 mmol). B5 yielded 2.90 g (8.88 mmol) of I-2 (41.5% yield) and 1.70 g (5.40 mmol) of I-3 (60.8% yield); B6 yielded 5.00 g (13.88 mmol) of I-2 (65.1% yield) and 2.50 g (7.18 mmol) of I-3 (51.7% yield); B7 yielded 3.20 g (8.62 mmol) of I-2 (52.5% yield) and 2.40 g (6.68 mmol) of I-3 (77.5% yield).

[0134] Example 18

[0135] Preparation of compound B1

[0136] 2.30 g (6.60 mmol) of 3-(trifluoromethyl)pyridin-2-yl substituted intermediate I-3 was reacted with 4-(trifluoromethyl)phenylhydrazine in a 1:2 molar ratio as described in Example 4. After the reaction was complete, the mixture was post-treated and purified as described in Example 4 to give 1.03 g (2.03 mmol) of compound B1, with an S4 yield of 30.8%, as a white solid with a melting point of 197.3–197.8 °C.

[0137] Example 19

[0138] Preparation of compound B2

[0139] 2.00 g (5.74 mmol) of 3-(trifluoromethyl)pyridin-2-yl substituted intermediate I-3 was reacted with 4-fluorophenylhydrazine in a 1:2 molar ratio as described in Example 4. After the reaction was complete, the mixture was post-treated and purified as described in Example 4 to give 0.70 g (1.53 mmol) of compound B2, with an S4 yield of 26.7%, as a white solid with a melting point of 201.9–202.4 °C.

[0140] Example 20

[0141] Preparation of compound B3

[0142] 1.80 g (5.72 mmol) of 3-chloropyridin-2-yl substituted intermediate I-3 was reacted with 4-fluorophenylhydrazine in a 1:2 molar ratio as described in Example 4. After the reaction was complete, the mixture was post-treated and purified as described in Example 4 to give 0.40 g (0.95 mmol) of compound B3, with an S4 yield of 16.5%, as a white solid with a melting point of 172.2–172.9 °C.

[0143] Example 21

[0144] Preparation of compound B4

[0145] 1.50 g (4.31 mmol) of 6-(trifluoromethyl)pyridin-2-yl substituted intermediate I-3 was reacted with phenylhydrazine at a molar ratio of 1:2 as described in Example 4. After the reaction was complete, the mixture was post-treated and purified as described in Example 4 to give compound B4 0.50 g (1.14 mmol), with an S4 yield of 26.5%, as a white solid with a melting point of 166.1–166.5 °C.

[0146] Example 22

[0147] Preparation of compound B5

[0148] 1.70 g (5.40 mmol) of 6-chloropyridin-2-yl substituted intermediate I-3 was reacted with phenylhydrazine at a molar ratio of 1:2 as described in Example 4. After the reaction was complete, the mixture was post-treated and purified as described in Example 4 to give 0.64 g (1.58 mmol) of compound B5, with an S4 yield of 29.3%, as a white solid with a melting point of 183.5–184.0 °C.

[0149] Example 23

[0150] Preparation of compound B6

[0151] 2.50 g (7.18 mmol) of 5-(trifluoromethyl)pyridin-2-yl substituted intermediate I-3 was reacted with 4-fluorophenylhydrazine in a 1:2 molar ratio as described in Example 4. After the reaction was complete, the mixture was post-treated and purified as described in Example 4 to give 1.35 g (2.96 mmol) of compound B6, with an S4 yield of 41.2%, as a white solid with a melting point of 149.9–150.3 °C.

[0152] Example 24

[0153] Preparation of compound B7

[0154] 2.40 g (6.68 mmol) of 6-bromopyridin-2-yl substituted intermediate I-3 was reacted with phenylhydrazine at a 1:2 molar ratio as described in Example 4. After the reaction was complete, the mixture was post-treated and purified as described in Example 4 to give 1.06 g (2.36 mmol) of compound B7, with an S4 yield of 35.3%, as a white solid with a melting point of 170.1–170.7 °C.

[0155] In vitro antibacterial activity assay

[0156] The in vitro inhibitory activity of A1-A37 against six plant pathogenic fungi was determined using the mycelial growth rate method. The tested pathogens were *Magnaporthe oryzae*, *Valsa mali*, *Fusarium graminearum*, *Sclerotinia sclerotiorum*, *Fusarium oxysporum*, and *Rhizoctonia solani*, and the strains were provided by Heilongjiang University.

[0157] Weigh 25 mg of the test compound, dissolve it in 1 mL of dimethyl sulfoxide, add two drops (0.10 mL) of polysorbate 80 to aid dispersion, and bring the volume to 10 mL with sterile water to obtain a 2.5 mg / mL stock solution. Take 1 mL of the stock solution and add it to 49 mL of sterilized potato dextrose agar medium and mix well to make the final concentration of the test compound 50 μg / mL and the final volume fraction of dimethyl sulfoxide approximately 0.2%.

[0158] A solvent control containing equal amounts of dimethyl sulfoxide and polysorbate 80 but without the test compound was set up. Approximately 10 mL of the drug-containing culture medium was poured into sterile 60 mm diameter petri dishes. After solidification, a 7 mm diameter mycelial disc was aspirated from the edge of the activated colony and inoculated into the center of the plate with the mycelial side down. Each treatment was performed in triplicate and incubated at 27.5 °C.

[0159] Once the solvent control colonies have grown to a suitable size, the colony diameter is measured using the cross-sectional method. Let D0 be the average diameter of the solvent control colonies, and D... t To determine the average colony diameter, the inhibition rate is calculated using the following formula: Inhibition rate (%) = [(D0-7)-(D...]] t -7)] / (D0-7)×100%. Data are expressed as mean ± standard deviation (n=3), and the measurement results are shown in Table 4.

[0160] Table 4 - In vitro antibacterial activity of A1-A37 at 50 μg / mL (inhibition rate / %, mean ± SD, n=3)

[0161]

[0162] Table 4 shows that A1-A37 exhibited varying degrees of inhibitory effects against the six plant pathogenic fungi. The average inhibition rates of A16 against *Strombus haematobium*, *Fungus foetida*, *Fusarium graminearum*, *Sclerotinia sclerotiorum*, and *Rhizoctonia solani* were 95.7±1.0%, 99.0±0.3%, 98.6±1.6%, 97.7±2.7%, and 85.3±0.6%, respectively.

[0163] Determination of half effective concentration

[0164] Based on the initial screening results of 50 μg / mL, compounds (A3, A16, A20) showing high activity against *Bacillus oryzae*, *Fungiella foenum-graecum*, *Fusarium graminearum*, and *Sclerotinia sclerotiorum* were selected. The concentration-response relationship was determined using the same mycelial growth rate method as the initial screening. The tested concentrations were 0.78125 μg / mL, 1.5625 μg / mL, 3.125 μg / mL, 6.25 μg / mL, 12.5 μg / mL, 25 μg / mL, and 50 μg / mL, with three replicates for each concentration. A linear regression was performed with the common logarithm of concentration as the independent variable x and the probability value obtained from the inhibition rate transformation as the dependent variable y. When y=5, the EC50 was calculated from the regression equation. 50 The results are shown in Table 5.

[0165] Table 5 - Virulence regression results of representative compounds against three plant pathogenic fungi

[0166]

[0167] Note: In Table 5, x is the common logarithm of the test concentration (μg / mL), and y is the probability value obtained by converting the inhibition rate.

[0168] Table 5 shows that A16 has EC50% resistance to rice blast fungus, apple rot fungus, Fusarium graminearum, and Sclerotinia sclerotiorum. 50 The concentrations were 0.550 μg / mL, 1.792 μg / mL, and 2.343 μg / mL, respectively, indicating that it still has a good inhibitory effect at low concentrations.

[0169] The above embodiments are only used to illustrate the technical solution of the present invention. Those skilled in the art can make conventional adjustments to the reaction scale, solvent amount, and operation method without departing from the concept of the present invention.

[0170] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the protection scope of the present invention.

Claims

1. A 1,2,4-triazolidinehydrazone compound containing a substituted phenyl ether structure, characterized in that, It is a compound represented by formula (I) or an isomer or mixture of isomers thereof, or a pharmaceutically acceptable salt: Equation (I); Wherein, the Ar 1 For R, which is chosen independently of one or two others 1 Substituted phenyl, or by an R 1 Substituted pyridin-2-yl; The Ar 2 It is a phenyl group or is formed by an R group. 2 Substituted phenyl; The R 1 Each of the following is independently selected from fluorine, chlorine, bromine, methyl, and trifluoromethyl; The R 2 It is selected from any one of fluorine, chlorine, bromine and trifluoromethyl.

2. The 1,2,4-triazolidinehydrazone compound containing a substituted phenyl ether structure as described in claim 1, characterized in that, When Ar 1 By an R 1 When replaced, the R 1 The substitution position is selected from 2, 3, or 4 bits; when Ar 1 By two R 1 When replaced, the two R 1 The replacement positions are 2 and 4.

3. The 1,2,4-triazolidinehydrazone compound containing a substituted phenyl ether structure as described in claim 1, characterized in that, The Ar 1 It is selected from any one of 3-(trifluoromethyl)pyridin-2-yl, 3-chloropyridin-2-yl, 5-(trifluoromethyl)pyridin-2-yl, 6-(trifluoromethyl)pyridin-2-yl, 6-chloropyridin-2-yl and 6-bromopyridin-2-yl, 4-fluorophenyl, 4-chlorophenyl, 4-bromophenyl, 3-fluorophenyl, 3-chlorophenyl, 3-bromophenyl, 3-(trifluoromethyl)phenyl, 2-fluorophenyl, 2-chlorophenyl, 2-bromophenyl, 2-fluoro-4-bromophenyl, 2-bromo-4-chlorophenyl, 2,4-dichlorophenyl, 4-methylphenyl, 2-fluoro-4-chlorophenyl, 2,4-difluorophenyl, 2-methylphenyl, and 2,4-dibromophenyl; The Ar 2 It is selected from any one of phenyl, 4-fluorophenyl, 4-chlorophenyl, 4-bromophenyl, 3-(trifluoromethyl)phenyl and 4-(trifluoromethyl)phenyl.

4. The 1,2,4-triazolidinehydrazone compound containing a substituted phenyl ether structure as described in claim 3, characterized in that, The compound is selected from any of the following Ar 1 and Ar 2 The compounds A1~A37 and compounds B1~B7 determined by combination: Compound A1: Ar 1 It is 4-fluorophenyl, Ar 2 It is a phenyl group; compound A2: Ar 1 It is 4-chlorophenyl, Ar 2 It is a phenyl group; compound A3: Ar 1 It is 4-bromophenyl, Ar 2 It is a phenyl compound; compound A4: Ar 1 It is 3-fluorophenyl, Ar 2 It is a phenyl group; compound A5: Ar 1 It is 3-chlorophenyl, Ar 2 It is a phenyl group; compound A6: Ar 1 It is 3-bromophenyl, Ar 2 It is a phenyl group; compound A7: Ar 1 It is 3-(trifluoromethyl)phenyl, Ar 2 It is a phenyl compound; compound A8: Ar 1 It is 2-fluorophenyl, Ar 2 It is a phenyl group; compound A9: Ar 1 It is 2-chlorophenyl, Ar 2 It is a phenyl group; compound A10: Ar 1 It is 2-bromophenyl, Ar 2 It is a phenyl group; compound A11: Ar 1 It is 2-fluoro-4-bromophenyl, Ar 2 It is a phenyl group; compound A12: Ar 1 It is 2-bromo-4-chlorophenyl, Ar 2 It is a phenyl group; compound A13: Ar 1 It is 2,4-dichlorophenyl, Ar 2 It is a phenyl group; compound A14: Ar 1 It is 4-fluorophenyl, Ar 2 It is 4-fluorophenyl; compound A15: Ar 1 It is 4-chlorophenyl, Ar 2 It is 4-fluorophenyl; compound A16: Ar 1 It is 4-methylphenyl, Ar 2 It is 4-fluorophenyl; compound A17: Ar 1 It is 3-fluorophenyl, Ar 2 It is 4-fluorophenyl; compound A18: Ar 1 It is 3-chlorophenyl, Ar 2 It is 4-fluorophenyl; compound A19: Ar 1 It is 3-bromophenyl, Ar 2 It is 4-fluorophenyl; compound A20: Ar 1 It is 3-(trifluoromethyl)phenyl, Ar 2 It is 4-fluorophenyl; compound A21: Ar 1 It is 2-fluorophenyl, Ar 2 It is 4-fluorophenyl; compound A22: Ar 1 It is 2-chlorophenyl, Ar 2 It is 4-fluorophenyl; compound A23: Ar 1 It is 2-fluoro-4-chlorophenyl, Ar 2 It is 4-fluorophenyl; compound A24: Ar 1 It is 2-fluoro-4-bromophenyl, Ar 2 It is 4-fluorophenyl; compound A25: Ar 1 It is 2-bromo-4-chlorophenyl, Ar 2 It is 4-fluorophenyl; compound A26: Ar 1 It is 4-chlorophenyl, Ar 2 It is 4-chlorophenyl; compound A27: Ar 1 It is 3-chlorophenyl, Ar 2 It is 4-chlorophenyl; compound A28: Ar 1 It is 4-bromophenyl, Ar 2 It is 4-chlorophenyl; compound A29: Ar 1 It is 2,4-difluorophenyl, Ar 2 It is 4-chlorophenyl; compound A30: Ar 1 It is 2-chlorophenyl, Ar 2 It is 4-(trifluoromethyl)phenyl; compound A31: Ar 1 It is 2-methylphenyl, Ar 2 It is 4-bromophenyl; compound A32: Ar 1 It is 3-fluorophenyl, Ar 2 It is 4-(trifluoromethyl)phenyl; compound A33: Ar 1 It is 3-chlorophenyl, Ar 2 It is 4-(trifluoromethyl)phenyl; compound A34: Ar 1 It is 3-bromophenyl, Ar 2 It is 4-(trifluoromethyl)phenyl; compound A35: Ar 1 It is 2,4-difluorophenyl, Ar 2 It is 4-(trifluoromethyl)phenyl; compound A36: Ar 1 It is 2,4-dibromophenyl, Ar 2 It is 4-(trifluoromethyl)phenyl; compound A37: Ar 1 It is 2-fluorophenyl, Ar 2 It is 3-(trifluoromethyl)phenyl; Compound B1: Ar 1 It is 3-(trifluoromethyl)pyridin-2-yl, Ar 2 It is 4-(trifluoromethyl)phenyl; Compound B2: Ar 1 It is 3-(trifluoromethyl)pyridin-2-yl, Ar 2 It is 4-fluorophenyl; compound B3: Ar 1 It is 3-chloropyridin-2-yl, Ar 2 It is 4-fluorophenyl; compound B4: Ar 1 It is 6-(trifluoromethyl)pyridin-2-yl, Ar 2 It is a phenyl group; compound B5: Ar 1 It is 6-chloropyridin-2-yl, Ar 2 It is a phenyl group; compound B6: Ar 1 It is 5-(trifluoromethyl)pyridin-2-yl, Ar 2 It is 4-fluorophenyl; compound B7: Ar 1 It is 6-bromopyridin-2-yl, Ar 2 It is a phenyl group.

5. A method for preparing the compound represented by formula (I) as described in any one of claims 1 to 4, characterized in that, Includes the following steps: Synthetic intermediates of aryloxyacetophenone ; The aryloxyacetophenone intermediate was subjected to an α-bromination reaction with a brominating reagent to obtain an α-bromoketone intermediate. ; The α-bromoketone intermediate was reacted with 1,2,4-triazole in the presence of a base to give a triazole-substituted ketone intermediate. ; The triazole-substituted ketone intermediate was condensed with a substituted phenylhydrazine in the presence of a catalyst to obtain the compound shown in formula (I); The chemical formula of the substituted phenylhydrazine is: .

6. The method for preparing the compound according to claim 5, characterized in that, The aryloxyacetophenone intermediate is a phenoxyacetophenone intermediate. or pyridoxyacetophenone intermediate n = 1 or 2; If the chemical formula of the aryloxyacetophenone intermediate is phenoxyacetophenone intermediate, its preparation method includes the following steps: The substituted phenol was reacted with 4-fluoroacetophenone in the presence of a base to give a phenoxyacetophenone intermediate; the chemical formula of the substituted phenol is [insert chemical formula here]. ; If the chemical formula of the aryloxyacetophenone intermediate is pyridinoxyacetophenone intermediate, its preparation method includes the following steps: reacting a substituted 2-halopyridine with 4-hydroxyacetophenone in the presence of a base to obtain the pyridinoxyacetophenone intermediate; the chemical formula of the substituted 2-halopyridine is... X is Cl or Br.

7. The method for preparing the compound according to claim 6, characterized in that, In the step of reacting substituted phenol with 4-fluoroacetophenone in the presence of a base to obtain a phenoxyacetophenone intermediate, the base is potassium carbonate, the solvent used is N,N-dimethylformamide, the reaction temperature is 130~135℃, and the reaction time is 12~15 h; the molar ratio of the substituted phenol, 4-fluoroacetophenone, and potassium carbonate is (1~1.5):(1.1~1.5):

2. In the step of reacting substituted 2-halopyridine with 4-hydroxyacetophenone in the presence of a base to obtain the pyridoxyacetophenone intermediate, the substituted 2-halopyridine is selected from one of 2-chloro-3-(trifluoromethyl)pyridine, 2,3-dichloropyridine, 2-chloro-6-(trifluoromethyl)pyridine, 2,6-dichloropyridine, 2-chloro-5-(trifluoromethyl)pyridine, and 2,6-dibromopyridine; the base is cesium carbonate, the solvent is dimethyl sulfoxide, the reaction temperature is 110~120℃, and the reaction time is 12~15h; the molar ratio of the substituted 2-halopyridine, 4-hydroxyacetophenone, and cesium carbonate is (1~1.5):(1~1.5):

2. In the step of reacting the aryloxyacetophenone intermediate with a brominating reagent via an α-bromination reaction to obtain an α-bromoketone intermediate, the brominating reagent is N-bromosuccinimide, the catalyst is p-toluenesulfonic acid monohydrate, the solvent is acetonitrile, the reaction temperature is 80-85 °C, and the reaction time is 8-10 h; the molar ratio of the aryloxyacetophenone intermediate, N-bromosuccinimide, and p-toluenesulfonic acid monohydrate is (1-1.5):(1.5-2.0):0.

1. In the step of reacting the α-bromoketone intermediate with 1,2,4-triazole in the presence of a base to obtain a triazole-substituted ketone intermediate, the base is potassium carbonate, the solvent is acetone, the reaction temperature is 0~2 °C, and the reaction time is 2~4 h; the molar ratio of the α-bromoketone, 1,2,4-triazole, and potassium carbonate is (1~1.5):(1.5~2.0):

2. In the step of condensing a triazole-substituted ketone intermediate with a substituted phenylhydrazine under a catalyst to obtain the compound shown in formula (I), the catalyst is acetic acid, the solvent is ethanol, the reaction temperature is 80~85 °C, and the reaction time is 8~10 h; the molar ratio of the triazole-substituted ketone intermediate to the substituted phenylhydrazine is (1~1.5):

2.

8. The use of a 1,2,4-triazolidinehydrazone compound containing a substituted phenyl ether structure as described in any one of claims 1 to 4 in the preparation of plant pathogenic fungicide inhibitors or plant fungicides.

9. The application as described in claim 8, wherein the plant pathogenic fungus is selected from at least one of rice blast fungus, apple rot fungus, Fusarium graminearum, Sclerotinia sclerotiorum, Fusarium oxysporum, and Rhizoctonia solani.

10. A method for preventing and controlling crop diseases, characterized in that, Includes the following steps: Applying a 1,2,4-triazole hydrazone compound containing a substituted phenyl ether structure as described in any one of claims 1 to 4 to crops.

Citation Information

Patent Citations

  • Bifepramide derivative, preparation method and purpose

    CN111978200A

  • Polysubstituted nitrogen-containing heterocyclic derivative as well as preparation method and application thereof

    CN115784988A